Liberty Mutual Group Asset Management’s GSK GSK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-18,800
Closed -$944K 340
2018
Q3
$944K Buy
+18,800
New +$955K 0.02% 413
2017
Q2
Sell
-23,391
Closed -$1.23M 965
2017
Q1
$1.23M Buy
23,391
+13,440
+135% +$682K 0.05% 561
2016
Q4
$479K Hold
9,951
0.02% 931
2016
Q3
$536K Hold
9,951
0.02% 876
2016
Q2
$539K Buy
9,951
+1,821
+22% +$95.9K 0.02% 881
2016
Q1
$412K Buy
+8,130
New +$405K 0.02% 918
2015
Q4
Sell
-5,920
Closed -$285K 996
2015
Q3
$285K Buy
+5,920
New +$308K 0.01% 1023
2014
Q4
Sell
-7,042
Closed -$405K 1031
2014
Q3
$405K Buy
+7,042
New +$432K 0.01% 1026

Other funds holding GSK

Liberty Mutual Group Asset Management's GSK Position: Q4 2018 in Review

Liberty Mutual Group Asset Management sold out of GSK (GSK) in Q4 2018, closing a stake of 18,800 shares — an estimated $944K sold.

Liberty Mutual Group Asset Management first reported a position in GSK in Q3 2014 and held it in 8 quarters. The position peaked at $1.23M in Q1 2017. 799 funds tracked by Wall St. Rank hold GSK as of Q4 2018.

  • Liberty Mutual Group Asset Management reported no remaining GSK position as of Q4 2018 after selling out during the quarter.
  • Liberty Mutual Group Asset Management sold 18,800 GSK shares in Q4 2018, an estimated $944K.
  • Liberty Mutual Group Asset Management first reported a position in GSK in Q3 2014 and held it in 8 quarters.
  • Liberty Mutual Group Asset Management's GSK position peaked at $1.23M in Q1 2017.
  • 799 funds tracked by Wall St. Rank held GSK as of Q4 2018.

Based on Liberty Mutual Group Asset Management's 13F filing for Q4 2018, filed 14 Feb 2019.